A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant
Clinical trial NCT00515138 · TERMINATED
Trial details
- NCT number
- NCT00515138
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.